Judges Scientific (JDG) Half Year 2023 results presentation - September 23

David Cicurel, CEO, Brad Ormsby, CFO, Mark Lavelle, COO and Tim prestige, Group Business Development Director present Half Year results for the six months ended 30th June 2023, followed by Q&A. Solid organic and acquisition growth and a 23% increase to interim dividend. David Cicurel, CEO 00:16 - Introduction 00:38 - About Judges Scientific 05:10 - Aqcuisition criteria 06:52 - The Judges Group 07:56 - HY23 Highlights Brad Ormsby, CFO 10:42 - HY23 Financial Highlights 14:30 - Group performance 15:45 - Order intake 17:31 - Profit Bridge 18:26 - Balance Sheet & Cashflow 21:19 - Diversification 21:53- Financial history David Cicurel, CEO 22:47 - Growth Drivers 23:20 - Henniker acquisition 24:06 - Bossa Nova Vision acquisition Mark Lavelle, COO 25:46 - Post aquisition strategy Tim Prestige, GBDD 31:13 - Post aquisition strategy continued David Cicurel, CEO 38:19 - Outlook 39:40 - Investement case 40:52 - Q&A Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 22 businesses acquired since 2005. The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export. The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins. Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.